Keratoderma, Palmoplantar, Diffuse
|
0.300 |
Biomarker
|
disease |
MGD |
Collectively, our data suggest that RHBDF2 plays a critical role in regulating EGFR signaling and its downstream events, including development of tylosis, by facilitating enhanced secretion of AREG.
|
28655741 |
2017 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Mutations in RHBDF2 cause tylosis, a very rare disorder characterized by high life-time risk of ESCC, but no other well-established predisposition genes have been identified.
|
28165652 |
2017 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
Biomarker
|
disease |
BEFREE |
Collectively, our data suggest that RHBDF2 plays a critical role in regulating EGFR signaling and its downstream events, including development of tylosis, by facilitating enhanced secretion of AREG.
|
28655741 |
2017 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
Biomarker
|
disease |
MGD |
The curly bare mouse model of tylosis, carrying a GOF mutation in the Rhbdf2 gene (Rhbdf2 <sup>cub</sup> ), presents with epidermal hyperplasia and shows accelerated cutaneous wound-healing phenotype through enhanced secretion of the epidermal growth factor receptor family ligand amphiregulin.
|
29116018 |
2017 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
A diagnosis of tylosis with oesophageal cancer is made on the basis of a positive family history, characteristic clinical features, including cutaneous and oesophageal lesions, and genetic analysis for mutations in RHBDF2.
|
26419362 |
2015 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Dominant iRHOM2 mutations are the cause of the inherited cutaneous and oesophageal cancer-susceptibility syndrome tylosis with oesophageal cancer (TOC), suggesting a role for this protein in epithelial cells.
|
24643277 |
2014 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.
|
22265016 |
2012 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
The tylosis oesophageal cancer (TOC) gene, localised to a small region on chromosome 17q25, has been shown to be associated with oesophageal squamous cell carcinoma.
|
17046844 |
2007 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
Biomarker
|
disease |
MGD |
Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
|
12573256 |
2003 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Moreover, a locus responsible for hereditary focal non-epidermolytic palmoplantar keratoderma (tylosis oesophageal cancer; TOC), a condition associated with esophageal cancer, has been mapped to the same band.
|
12691822 |
2003 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
Biomarker
|
disease |
BEFREE |
Moreover, a genetic locus for hereditary focal non-epidermolytic palmoplantar keratoderma, a condition associated with cancer of the esophagus (TOC; Tylosis with Oesophageal Cancer), lies in the same region.
|
11346464 |
2001 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
The causative locus, the tylosis esophageal cancer (TOC) gene, has been localized to a small region on chromosome 17q25.
|
10631907 |
1999 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Loss of heterozygosity in sporadic oesophageal tumors in the tylosis oesophageal cancer (TOC) gene region of chromosome 17q.
|
9798681 |
1998 |
Keratoderma, Palmoplantar, Diffuse
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Recently, the tylosis oesophageal cancer (TOC) gene locus has been mapped to 17q25 by linkage analyses of pedigrees with focal nonepidermolytic palmoplantar keratoderma associated with a high risk of esophageal cancer development.
|
9609757 |
1998 |